Chemical identity
Celecoxib Inhouse Impurity CAS 53764-99-1
CAS 53764-99-1 · C11H9F3O2
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-10250 |
|---|---|
| PubChem CID | 18624099 |
| Name | Celecoxib Inhouse Impurity CAS 53764-99-1 |
| CAS RN | 53764-99-1 |
| Molecular formula | C11H9F3O2 |
| Molecular weight | 230.18 |
| IUPAC name | 4,4,4-Trifluoro-1-(m-tolyl)butane-1,3-dione |
| InChIKey | VOFWLZQTWRLBTR-UHFFFAOYSA-N |
02Structure identifiers

The parsed structure contains 1 ring, includes aromatic atoms, includes aliphatic carbon, contains at least one halogen atom. These statements are calculated from the published structure string.
| Defined stereocentres | 0 |
|---|---|
| Unassigned stereocentres | 0 |
| Ring count | 1 |
| Secondary amines | 0 |
| Tertiary amines | 0 |
| N-methyl amine sites | 0 |
| SMILES | CC1=CC(=CC=C1)C(=O)CC(=O)C(F)(F)F |
|---|---|
| InChI | Not listed |
| Formula from structure | C11H9F3O2 |
| Molecular weight from structure | 230.18 |
03India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NO EXACT MATCH FOUND | CAS 53764-99-1 has no exact match in the reviewed published schedule. |
|---|---|---|
| SCOMET | NO EXACT REVIEWED CAS MATCH | CAS 53764-99-1 has no exact match in the reviewed SCOMET list. |
| Review date | 2026-08-01 | Recheck the current official instruments for the material, concentration, activity and date in question. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · reviewed 2026-08-01
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · reviewed 2026-08-01
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · reviewed 2026-08-01
04Names and relationships
Associated parent compound
Celecoxib
View API and impurity familyOther names
- Celecoxib Inhouse Impurity
- 4,4,4-Trifluoro-1-(m-tolyl)butane-1,3-dione
- 53764-99-1
- 4,4,4-Trifluoro-1-(3-methylphenyl)-1,3-butanedione
- 4,4,4-trifluoro-1-(3-methylphenyl)butane-1,3-dione
- MFCD11849497
- 1,1,1-Trifluoro-4-(3'-methylphenyl)butane-2,4-dione
- Moxifloxacin Impurity 14
- Moxifloxacin Impurity 55
- 7QCX472V3H
- SCHEMBL1924595
- 1,3-Butanedione, 4,4,4-trifluoro-1-(3-methylphenyl)-
05Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
06Sources
- S01PubChem compound record, CID 18624099
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
